Shawna S
banner
shawna-san.bsky.social
Shawna S
@shawna-san.bsky.social
• 808 ✈️ 402 • creighton alum • UNMC/Neb Med trained • mostly here for the HIV/ID content 🦠💉💊 •
really excited to share this real world LA CAB/RPV PK in pregnancy data !! thanks @unmc-id.bsky.social and @unm.edu for collaborating!!
Long-Acting Cabotegravir/Rilpivirine for Treatment of HIV During Pregnancy: A Case Series

✅ Just Accepted
#IDSky
🔗 https://bit.ly/4hxXPjI
November 3, 2025 at 6:54 PM
Reposted by Shawna S
We’re proud to celebrate the remarkable researchers and leaders being recognized at the 2025 Distinguished Scientist Awards on Nov. 6! Throughout the month, we’ll spotlight our awardees’ achievements.

Distinguished Scientist: Anthony Podany, PharmD, PhD
www.unmc.edu/newsroom/202...
October 30, 2025 at 5:15 PM
Reposted by Shawna S
Our division had a great #IDWeek2025! We had 44 presentations from 30 members of our division in attendance! All of our fellows were able to attend, and it was great to see many from our division on the big stage! @idweek.bsky.social
October 27, 2025 at 2:17 PM
Reposted by Shawna S
@nkusnikmd.bsky.social presenting our blood culture shortage experience during an oral abstract session appropriately titled “A Bloody Mess!” @idweek.bsky.social #IDWeek2025 @unmc-id.bsky.social
October 21, 2025 at 7:39 PM
Reposted by Shawna S
This isn't even a slight exaggeration. He is actively working on destroying the US's entire vaccine infrastructure. The HepB vote will be tomorrow, where they will get rid of the birth dose and recommend it at 30 days, dooming a bunch of infants to chronic infection ft. cirrhosis, cancer, and death.
September 18, 2025 at 11:18 PM
Reposted by Shawna S
So proud of my M4 mentee, Natalie Sturd, who was one of only two trainees selected to give an oral presentation at the Nebraska ID Society Conference today! She presented a case of KS-IRIS and highlighted the importance of honoring our patients through the learning process. #NIDS #IDSky
August 15, 2025 at 10:29 PM
Reposted by Shawna S
New case report led by @shawna-san.bsky.social with many @unmc-id.bsky.social collaborators in @ofidjournal.bsky.social:

"Sustained HIV Viral Suppression 18 Months Post-Last Dose of Long-Acting CAB/RPV" #IDSky #HIVSky

academic.oup.com/ofid/advance...
Sustained HIV Viral Suppression 18 Months Post-Last Dose of Long-Acting Cabotegravir/Rilpivirine: A Case Report
Abstract. Long-acting cabotegravir/rilpivirine offers a low incidence of virologic failure. However, drug resistance can develop after discontinuation with
academic.oup.com
July 11, 2025 at 3:33 PM
Reposted by Shawna S
Check out the great work from our Specialty Care Clinic at the International HIV Conference in Puerto Rico in our latest blog post!

- Long-acting ART implementation in Midwest
- HIV ECHO in Sudan
- Depression screening
- Digital HIV education

#IDSky #HIVSky

blog.unmc.edu/infectious-d...
Strong Representation from UNMC Specialty Care Clinic at International HIV Conference - Division of Infectious Diseases
Several representatives of the UNMC/NM Specialty Care Center attended the 20th anniversary of the Continuum Conference (formerly Adherence Conference) in San Juan, Puerto Rico. This is an annual confe...
blog.unmc.edu
July 8, 2025 at 7:07 PM
Reposted by Shawna S
Catastrophic.
This is a travesty & a nightmare. The US was a founder of @gavi.org. It lowers global vaccine costs, has vaccinated 1B children, & averted 19M deaths. This pull out will cost 100s of thousands of children's lives a year - and RFK Jr will be personally responsible.
www.politico.com/news/2025/06...
RFK Jr. says US won’t donate to global vaccine effort
Kennedy ripped into Gavi, the Vaccine Alliance, in a video address at its pledging summit.
www.politico.com
June 25, 2025 at 2:35 PM
Reposted by Shawna S
Implementation of an online drug-drug interaction screener for the STRIVE ensitrelvir trial for COVID-19

✅ Just Accepted
⭐ Editor's Choice
#IDSky
Implementation of an online drug-drug interaction screener for the STRIVE ensitrelvir trial for COVID-19
Ensitrelvir is an antiviral agent against SARS-CoV-2 with associated drug-drug interactions (DDI) through CYP3A, P-gp, BCRP, and OAT-3 inhibition.
doi.org
June 14, 2025 at 2:33 PM
Reposted by Shawna S
It’s #Pride! The perfect time to take pride in:

✔️ Yourself

✔️ Your health

✔️ Your HIV status

Celebrate pride by getting tested for #HIV. Find a testing site or where to get a self-test near you: bit.ly/3xnJwc3 #StopHIVTogether
June 11, 2025 at 4:09 PM
Reposted by Shawna S
This is such an important shift. For many years the catholic church withheld support for HPV vaccination which prevents cervical cancer.
119,000 women die from this cancer in Africa every year.
This full throated support of the HPV vaxx by the church will help uptake.
nation.africa/kenya/health...
We can't remain indifferent to suffering: Catholic Church now champions HPV vaccination
From opposition to advocacy: After dismissing vaccine over promiscuity fears, church now tells faithful early intervention saves lives
nation.africa
May 16, 2025 at 9:14 PM
Reposted by Shawna S
Sofosbuvir/Velpatasvir Pharmacokinetics, Safety, and Efficacy in Pregnant People With Hepatitis C Virus

#IDSky
Sofosbuvir/Velpatasvir Pharmacokinetics, Safety, and Efficacy in Pregnant People With Hepatitis C Virus
Treatment of hepatitis C virus (HCV) during pregnancy can cure maternal HCV and prevent perinatal HCV transmission. The primary objective was to compare the pharmacokinetics (PK) of sofosbuvir (SOF)/velpatasvir (VEL) in pregnant versus nonpregnant people.
academic.oup.com
May 11, 2025 at 6:58 PM
Reposted by Shawna S
Great oral presentation at #SHEASpring2025 on the impact of the blood culture shortage in SEP-1 performance by @unmc-id.bsky.social faculty @jonathanrydermd.bsky.social
April 30, 2025 at 3:23 PM
Reposted by Shawna S
On going backwards

Chris Beyrer

"We are at a moment when the USA is moving backwards on the response to HIV and backwards on vaccines... And the list goes on. That these are deliberately inflicted wounds makes them all the more difficult to bear."

www.thelancet.com/journals/lan...
On going backwards
There are patients you can never forget. Some because you connected unusually deeply with them as people or with their stories—some because you may have seen yourself or a loved one in their shoes, on...
www.thelancet.com
April 26, 2025 at 9:40 PM
Reposted by Shawna S
The first draft is where you explain it to yourself. The second draft is where you explain it to your readers
April 24, 2025 at 11:00 AM
Reposted by Shawna S
Noticeably silent amid the upheaval at HHS? Big pharma. Every new drug has NIH somewhere in its DNA--and NIH funding supports the training of their workforce. Now they're finding out FDA isn't safe, either. Wrote about how keeping quiet isn't working My latest @opinion.bloomberg.com (gift link):
Big Pharma Needs to Get Off the Sidelines
The industry can’t continue to sit idly by while Robert F. Kennedy Jr. guts the nation’s public health agencies.
www.bloomberg.com
April 1, 2025 at 3:08 PM
Reposted by Shawna S
Long-acting injectable HIV therapy outcomes among persons with HIV who have adherence challenges to oral antiretroviral therapy

✅ Just Accepted
#IDSky
Long-acting injectable HIV therapy outcomes among persons with HIV who have adherence challenges to oral antiretroviral therapy
Long-acting injectable cabotegravir/rilpivirine (LAI-CAB/RPV) may improve outcomes among persons with HIV (PWH) with adherence difficulties to oral therapy.
doi.org
March 20, 2025 at 6:58 PM
Reposted by Shawna S
aidsmap's first summary bulletin of news from #CROI2025 is out now.
CROI 2025: US funding freeze threatens two decades' progress in HIV, 13 March 2025 https://www.aidsmap.com/bulletin/conference-news/croi-2025/13-march-2025
March 13, 2025 at 9:38 AM
Reposted by Shawna S
Doxycycline postexposure prophylaxis for bacterial STIs: Prescribing patterns, use, short-term outcomes among 2083 patients in a Los Angeles Federally Qualified Health Care Program, and implications for widespread use.

✅ Just Accepted
#IDSky
Doxycycline postexposure prophylaxis for bacterial STIs: Prescribing patterns, use, short-term outcomes among 2083 patients in a Los Angeles Federally Qualified Health Care Program, and implications for widespread use.
Rates of bacterial sexually transmitted infections (STIs) have risen dramatically over the past decades. Doxycycline postexposure prophylaxis (DP) is a novel intervention to prevent bacterial STIs. Recent randomized controlled clinical trials reported high DP efficacy at preventing syphilis and chlamydia in cisgender men who have sex with men (MSM) and transgender women.
buff.ly
February 20, 2025 at 10:11 PM
a stellar pub by stellar resident, @saraharduser.bsky.social 🤩 and s/o to @jonathanrydermd.bsky.social for the Dolly x ASP collab we never knew we needed 🤝
February 18, 2025 at 12:44 AM
as the kids say … first #IDSky post, kinda nervous 🫣 but excited to share our clinic’s early utilization of doxy PEP data 📈📊
February 8, 2025 at 6:15 PM